New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein

Details for Australian Patent Application No. 2010204547 (hide)

Owner Teva Pharmaceutical Industries, Ltd.

Inventors Bock, Jason Benjamin; Luo, Xia

Agent Davies Collison Cave

Pub. Number AU-A-2010204547

PCT Pub. Number WO2010/083434

Priority 61/145,436 16.01.09 US; 61/145,440 16.01.09 US

Filing date 15 January 2010

Wipo publication date 22 July 2010

International Classifications

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/083434 Priority application(s): WO2010/083434

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010204552-New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein

2010204546-Pressure measuring syringe